IDO1 and myeloid sarcoma: In experimental autoimmune encephalomyelitis (EAE), an animal model for MS, IDO1 activity is increased in the spleen during pre-clinical phases, and IDO1-positive microglia and macrophages have been detected in brain and spinal cord at symptom onset, correlating with disease severity.